Stage-sensitive blockade of pituitary somatomammotrope development by targeted expression of a dominant negative epidermal growth factor receptor in transgenic mice

Molecular Endocrinology

Volumn 15, Issue 4, 2001, Pages 600-613

  Roh, Meejeon ^b   Paterson, Andrew J ^a   Asa, Sylvia L ^c   Chin, Edward ^a   Kudlow, Jeffrey E ^a,b,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH HORMONE; PROLACTIN; TETRACYCLINE; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FEMALE; HYPOPHYSIS CELL; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0035054851     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.15.4.0625     Document Type: Article

References (69)

1. Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary
2. Formation of Rathke's pouch requires dual induction from the diencephalon
3. Multistep signaling requirements for pituitary organogenesis in vivo
4. Six 3, a murine homologue of the sine oculis gene, demarcates the most anterior border of the developing neural plate and is expressed during eye development
5. Sequence, genomic organization, and expression of the novel homeobox gene Hesx1
6. Rpx: A novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo
7. Pax-6, a murine paired box gene, is expressed in the developing CNS
8. P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1
9. Expression of the murine LIM class homeobox gene Lhx3 in subsets of neural and neuroendocrine tissues
10. Ptx-1, a bicoid-related homeobox transcription factor involved in transcription of the proopiomelanocortin gene
11. P-OTX: A PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development
12. Pit-1 determines cell types during development of the anterior pituitary gland
13. The hypothalamic-pituitary axis: Co-development of two organs
14. The cytogenesis and pathogenesis of pituitary adenomas
15. Molecular determinants of pituitary cytodifferentiation
16. Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types
17. Kinetics of thyrotrophs and somatotrophs during development of hypothyroidism and L-triiodothyronine treatment of hypothyroid rats
18. Determination of cell number of each cell type in the anterior pituitary of euthyroid and hypothyroid rats
19. Kinetics of deoxyribonucleotide acid synthesis and replication of thyrotrophs and somatotrophs during development of hypothyroidism and L-triiodothyronine treatment of hypothyroid rats
20. Prolactin cells in the human pituitary. A quantitative immunocytochemical analysis
21. Immunocytochemical localization of human epidermal growth factor/urogastrone in several human tissues
22. Distribution of epidermal growth factor binding sites in the adult rat anterior pituitary gland
23. α-Transforming growth factor in bovine anterior pituitary gland: Secretion by dispersed cells and immunohistochemical localization
24. Epidermal growth factor and transforming growth factor-α messenger ribonucleic acids and their receptors in the rat anterior pituitary: Localization and regulation
25. Synthesis of messenger RNAs for transforming growth factor α and β and the epidermal growth factor receptor by human tumors
26. Transforming growth factor α in normal and neoplastic human endocrine tissues
27. Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro
28. Membrane-anchored expression of transforming growth factor-alpha in human pituitary adenoma cells
29. The c-erbB-2/neu proto-oncogene in human pituitary tumors
30. Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness
31. Epidermal growth factor stimulates growth hormone secretion from superfused rat adenohypophyseal fragments
32. Epidermal growth factor stimulates secretion of rat pituitary luteinizing hormone in vitro
33. Epidermal growth factor stimulates luteinizing hormone and arachidonic acid release in rat pituitary cells
34. Epidermal growth factor enhances ACTH secretion and expression of POMC mRNA by corticotropes in mixed and enriched cultures
35. Epidermal growth factor stimulates thyrotropin secretion in the rat
36. Involvement of transforming growth factor alpha in the release of luteinizing hormone-releasing hormone from the developing female hypothalamus
37. Growth hormone enhances hepatic epidermal growth factor receptor concentration in mice
38. Dopamine receptor activation inhibits estrogen stimulated transforming growth factor-α gene expression and growth in anterior pituitary, but not in uterus
39. Expression of transforming growth factor-α and its messenger rinonucleic acid in human breast cancer: Its regulation by estrogen and its possible functional significance
40. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development
41. Transgenic mice with inducible dwarfism
42. Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure
43. Transcriptional activation by tetracyclines in mammalian cells
44. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice
45. Conditional expression of the erbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFα expression in transgenic mice
46. Conditional transformation of a pancreatic β-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene
47. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen
48. Control of memory formation through regulated expression of a CaMKII transgene
49. Conditional transgene expression in the heart
50. Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory
51. Synergistic interactions between Pit-1 and other elements are required for effective somatotroph rat growth hormone gene expression in transgenic mice
52. Ontogeny of growth hormone and prolactin gene expression in mice
53. The Ames dwarf gene is required for Pit-1 gene activation
54. Gonadotropin secretion, synthesis, and gene expression in human growth hormone transgenic mice and in Ames dwarf mice
55. Effects of growth hormone on neuroendocrine function
56. The role of growth hormone in the control of gonadotropin secretion in adult male rats
57. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor
58. Strain-dependent epithelial defects in mice lacking the EGF receptor
59. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype
60. Targeting of transforming growth factor-α expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas
61. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype
62. The Pit-1 transcriptional factor gene is a candidate for the murine Snell dwarf mutation
63. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene Pit-1
64. Molecular basis of the little mouse phenotype and implications for cell type-specific growth
65. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas
66. GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumors
67. A new constitutively activating mutation of the Gs protein α subunit-gsp oncogene is found in human pituitary tumors
68. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene
69. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction